drugset / Trial / NCT07016464
A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.
RandomizedSequentialQuadruple-blindTreatment
Summary
This study is testing if the medicine REM0045392 is safe and well-tolerated. It also looks at whether food affects how the medicine works. The medicine will be tested in Healthy men (Part 1 and 2) and Healthy Older men and women (Part 3). Participants will take the medicine once (in Part 1) or during 14 days (in Part 2 and 3), with increasing doses. REM0045392 is being developed as a treatment for Alzheimer's disease.
Timeline
- Start
- 2025-03-20
- Primary completion
- 2025-06-23
- Completion
- 2025-06-23
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REM0045392 | Unknown | — | — |
Indications
No indication recorded.